Last reviewed · How we verify
NCT06383117
Understanding Effects of Calcium on the Gut-Bone Axis
NA trial testing Calcium carbonate in Healthy in 14 participants. Completed in 23 February 2024.
23 February 2024
Quick facts
| Lead sponsor | University of Georgia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 14 |
| Start date | 17 October 2023 |
| Primary completion | 23 February 2024 |
| Estimated completion | 23 February 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Calcium carbonate (calcium carbonate) — full drug profile →
- Placebo Control
Conditions studied
- Healthy — all drugs for Healthy →
- Adult — all drugs for Adult →
- Calcium — all drugs for Calcium →
- Bone Resorption — all drugs for Bone Resorption →
Sponsor
University of Georgia
Who can join
Adults 18 to 45, any sex, with Healthy or Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study team is inviting 13 healthy people to complete a study to explore how calcium affects hormones and bones after eating. Participants will be asked to complete two study visits within eight weeks. Before each visit, participants will be asked to not eat or drink (except water) for 9 hours. At each visit, participants will eat the same meal provided by the research team. Along with their meal, they will take a pill - in one session, this will be a calcium supplement, and in the other, a placebo (a pill with no calcium), but they won't know which one they are taking at which session. A phlebotomist will draw blood before the meal and pill, then again several times after eating. Blood draws will take place over three hours. During that time, participants will complete questionnaires about health, diet, and physical activity. Blood will be analyzed to check on various health indicators, like bone health markers and certain hormones, to see how they change after the meal. The difference in these health indicators between the calcium and placebo sessions will help the study team understand the impact of calcium on health after eating. This could help increase knowledge of the impact of calcium on hormones and bone health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06383117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium carbonate
Trials testing the same drug.
- NCT07056062 — Oral Calcium Supplementation in Labor · Phase 2, PHASE3 · completed
- NCT05381168 — Calcium From Fish Bone in Volunteers With Osteopenia · NA · unknown
- NCT05313477 — The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF · Phase 4 · completed
- NCT05559619 — Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal Women · NA · completed
- NCT03837886 — Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task · NA · unknown
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of Georgia trials
Trials by the same sponsor.
- NCT07173816 — Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and S · NA · not yet recruiting
- NCT06799702 — Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje · NA · not yet recruiting
- NCT06987526 — Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alco · NA · recruiting
- NCT06193343 — Steps Towards Osteoarthritis Prevention · NA · recruiting
- NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06383117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Georgia
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06383117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing